ASK1 Restores the Antiviral Activity of APOBEC3G by Disrupting HIV-1 Vif-Mediated Counteraction

Nature Communications - United Kingdom
doi 10.1038/ncomms7945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Activity Spectrum of Vif From Multiple HIV-1 Subtypes Against APOBEC3G, APOBEC3F, and APOBEC3H

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

Structure of the Vif-Binding Domain of the Antiviral Enzyme APOBEC3G

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2015English

Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2007English

Phosphorylation of APOBEC3G by Protein Kinase a Regulates Its Interaction With HIV-1 Vif

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2008English

HIV-1 Vif Inhibits G to a Hypermutations Catalyzed by Virus-Encapsidated APOBEC3G to Maintain HIV-1 Infectivity

Retrovirology
VirologyInfectious Diseases
2014English

Suppression of APOBEC3-mediated Restriction of HIV-1 by Vif

Frontiers in Microbiology
Microbiology
2014English

Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2016English

Identification of a Novel HIV-1 Inhibitor Targeting Vif-Dependent Degradation of Human APOBEC3G Protein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

The Dimerization Domain of HIV-1 Viral Infectivity Factor Vif Is Required to Block Virion Incorporation of APOBEC3G

Retrovirology
VirologyInfectious Diseases
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy